| # | Country | Total Patents | |
|---|---|---|---|
| #1 | China | 2 | |
| #2 | EPO (European Patent Office) | 2 | |
| #3 | Republic of Korea | 2 | |
| #4 | Australia | 1 | |
| #5 | Brazil | 1 | |
| #6 | Canada | 1 | |
| #7 | Singapore | 1 | |
| #8 | United States | 1 | |
| #9 | WIPO (World Intellectual Property Organization) | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Measurement | |
| #3 | Biotechnology |
| # | Technology | |
|---|---|---|
| #1 | Peptides | |
| #2 | Analysing materials | |
| #3 | Therapeutic chemical compounds | |
| #4 | Medical preparations |
| # | Name | Total Patents |
|---|---|---|
| #1 | Jiang Wei-Dong | 9 |
| #2 | Lin Pei-Hua | 9 |
| #3 | Tseng Chi-Ling | 5 |
| #4 | Jiang Wei Dong | 2 |
| #5 | Lin Pei Hua | 2 |
| #6 | Wei-Dong Jiang | 1 |
| #7 | Chi-Ling Tseng | 1 |
| #8 | Pei-Hua Lin | 1 |
| #9 | Tseng Chi Ling | 1 |
| Publication | Filing date | Title |
|---|---|---|
| AU2016288192A1 | Anti-vascular endothelial growth factor receptor 2 (VEGFR2) antibodies | |
| CN106714830A | Anti-epidermal growth factor receptor (egfr) antibodies |